Transforming Growth Factor B1 T29C Polymorphism and Breast Cancer Risk in Japanese Women
スポンサーリンク
概要
- 論文の詳細を見る
- 2003-01-31
著者
-
Maeda S
Center For Hematopoietic Disorders Ohta Nishinouchi Hospital The Ohta Foundation
-
Miura S
Division Of Molecular Medicine Aichi Cancer Center Research Institute
-
Seto M
Department Of Hematology And Chemotherapy
-
Seto M
Aichi Cancer Center Res. Inst. Nagoya
-
Ichimiya Hitoshi
Division Of Surgery Hamanomachi General Hospital
-
Ito Hidemi
愛知県がんセンター研究所 疫学･予防部
-
TAJIMA Kazuo
Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute
-
HIROSE Kaoru
Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute
-
HAMAJIMA Nobuyuki
Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute
-
Hirose Kaoru
名古屋大学 医学部産婦人科
-
Kato T
Department Of Gastroenterological Surgery Aichi Cancer Center Hospital
-
Matsuo K
Division Of Epidemiology And Prevention Aichi Cancer Center Research Institute
-
Matsuo Keitaro
愛知県がんセンター研究所 疫学･予防部
-
Matsuo Keitaro
Division Of Epidemiology And Prevention Aichi Cancer Center Research Institute
-
MIURA Shigeto
Department of Breast Surgery, Aichi Cancer Center Hospital
-
Sawa Masashi
Department Of Molecular Medicine And Hematology Nagoya University Graduate School Of Medicine
-
Hishida Asahi
Department Of Hematology Nagoya University Graduate School Of Medicine
-
Hishida Asahi
名古屋大学 医学系研究科予防医学
-
Hamajima N
Department Of Preventive Medicine-biostatistics And Medical Decision Making Nagoya University Gradua
-
Hamajima Nobuyuki
愛知県がんセンター研究所 疫学･予防部
-
Hamajima Nobuyuki
Department Of Preventive Medicine/biostatistics And Medical Decision Making Nagoya University Gradua
-
Murakami Masato
Department Of Radiology Ehime Prefectural Central Hospital
-
SANO Masayuki
Departments of Internal Medicine Saga Medical School
-
Sakai Mari
Department Of Hematology And Molecular Medicine Unit Atomic Bomb Disease Institute Nagasaki Universi
-
Iwata Hiroji
Department of Breast Surgery, Aichi Cancer Center
-
Hirose K
Division Of Epidemiology And Prevention Aichi Cancer Center Research Institute
-
Kuroisi Tetsuo
The Division Of Epidemiology And Prevention Aichi Cancer Center Research Institute
-
IWASE Takuji
Department of Breast Oncology, The Cancer Institute Hospital of the Japanese Foundation for Cancer R
-
Sano Masayuki
Niigata Cancer Center Hospital
-
Iwase Takuji
Department Of Breast Oncology Cancer Institute Hospital Japanese Foundation For Cancer Research
-
Iwase T
Departmet Of Breast Surgery Aichi Cancer Center And Nagoya University Graduate School Of Medicine Ja
-
EMI Nobuhiko
First Department of Internal Medicine
-
Tajima Kazuo
Aichi Cancer Center Research Institute
-
Emi Nobuhiko
名古屋大学 医学系研究科血液･腫瘍内科学
-
Emi Nobuhiko
First Department Of Internal Medicine Nagoya University Graduate School Of Medicine
-
Emi Nobuhiko
The First Department Of Internal Medicine Nagoya University School Of Medicine
-
MIZUTANI Mitsuhiro
Department of Breast Surgery, Aichi Cancer Center Hospital
-
Hirose Kaoru
Division Of Epidemiology And Prevention Aichi Cancer Center Research Institute
-
Hirose K
Department Of Planning And Information Aichi Prefectural Institute Of Public Health
-
Shamoto M
Fujita Health Univ. Toyoake Jpn
-
Minami S
Nagasaki Cml Study Group
-
HISHIDA Asahi
Division of Epidemiology and Prevention, Aichi Cancer Center
-
Matsuda Shin
Center For Hematopoietic Disorders Ohta Nishinouchi Hospital The Ohta Foundation
-
Miura Shigeto
Department Of Breast Surgery Aichi Cancer Center Hospital
-
Matsuo Keitaro
Division Of Epidemiology And Prevention Aichi Cancer Center
-
Mori Shin‐ichiro
Hematopoietic Stem Cell Transplantation Division National Cancer Center Hospital
-
Hamajima Nobuyuki
Division Of Epidemiology Aichi Cancer Center Research Institute
-
Iwata H
Department Of Breast Oncology Aichi Cancer Center Hospital
-
Iwata Hiroji
Department Of Breast Oncology Aichi Cancer Center Hospital
-
Mizutani Mitsuhiro
Department Of Breast Surgery Aichi Cancer Center And Nagoya University Graduate School Of Medicine J
-
Mizutani Mitsuhiro
Department Of Breast Oncology Aichi Cancer Center Hospital
-
Kano Mayuko
Medical Student Of Nagoya University School Of Medicine Department Of Preventive Medicine-biostatist
-
Imaizumi Takeshi
Department Of Preventive Medicine Faculty Of Medicine Saga University
-
Mizuno Masayuki
Departments Of Gastroenterology And Hepatology Saiseikai Suita Hospital
-
Tajima Kazuo
Division Of Epidemiology Aichi Cancer Center Research Institute
-
Kato Motoichiro
Department Of Neuropsychiatry Tokyo Medical And Dental University Ichikawa General Hospital
-
Iwata Hiroji
Department Of Breast Surgery Aichi Cancer Center Hospital
-
Iwase Hirotaka
Department Of Surgery Ii Breast And Endocrine Surgery Nagoya City University Medical School
-
Matsuo Keitaro
Department Of Epidemiology And Prevention Aichi Cancer Center Research Institute
-
Iwata H
Department Of Internal Medicine And Molecular Science Nagoya City University Graduate School Of Medi
-
Emi N
Department Of Hematology Nagoya University Graduate School Of Medicine
-
Mizutani M
Department Of Breast Oncology Aichi Cancer Center Hospital
-
Seto Masao
Department Of Hematology/oncology Nagoya National Hospital
-
Hirabayashi Noriyuki
Department Of Hematology Nagoya Daini Red Cross Hospital
-
Hishida Asahi
Division Of Epidemiology And Prevention Aichi Cancer Center Research Institute
-
Moritaka S
Department Of Surgery Ii Nagoya City University Medical School
-
Hirose Kaoru
Division Of Epidemiology
-
Miura Shigeto
Department Of Surgery Aichi Cancer Center
-
Hiraki Akio
Department Of Gynecology And Obstetrics Nagoya University Graduate School Of Medicine
-
Suzuki Masumi
Department Of Thoracic Surgery Aichi Cancer Center Hospital
-
Mizokami Masashi
Department Of Internal Medicine Murakami Memorial Hospital
-
Matsuo Keitaro
Division of Cardiology, Nippon Medical School
関連論文
- Allogeneic stem cell transplantation versus chemotherapy as post-remission therapy for intermediate or poor risk adult acute myeloid leukemia : results of the JALSG AML97 study
- Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia : the JALSG AML95 study
- Outcome of allogeneic bone marrow transplantation from unrelated donors for adult Philadelphia chromosome-negative acute lymphocytic leukemia in first complete-remission
- Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan
- Long-term efficacy of imatinib in a practical setting is correlated with imatinib trough concentration that is influenced by body size : a report by the Nagasaki CML Study Group
- Management of infection in patients with acute leukemia during chemotherapy in Japan : questionnaire analysis by the Japan Adult Leukemia Study Group
- Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
- Unrelated-Donor Bone Marrow Transplantation with a Conditioning Regimen Including Fludarabine, Busulfan, and 4 Gy Total Body Irradiation
- Japanese phase II study of ^Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma
- The clinical characteristics of CD7^+ CD56^+ acute myeloid leukemias other than M0
- Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia : final results of Japanese multicenter cooperative study
- Hematopoietic stem cell transplantation for acute promyelocytic leukemia in second or third complete remission : a retrospective analysis in the Nagoya Blood and Marrow Transplantation Group
- Diagnosis of acute myeloid leukemia according to the WHO classification in the Japan Adult Leukemia Study Group AML-97 protocol
- BMI-1 Is Highly Expressed in M0-Subtype Acute Myeloid Leukemia
- Phase I Trial of FLAGM with High Doses of Cytosine Arabinoside for Relapsed, Refractory Acute Myeloid Leukemia : Study of the Japan Adult Leukemia Study Group (JALSG)
- Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation for Multiple Myeloma : Results from the Japan Myeloma Study Group
- Phase III study to evaluate the use of high-dose chemotherapy as consolidation of treatment for high-risk postoperative breast cancer : Japan Clinical Oncology Group study, JCOG 9208
- Comparative Case-referent Study of Risk Factors among Hormone-related Female Cancers in Japan
- No beneficial effect from addition of etoposide to daunorubicin,cytarabine,and 6-mercaptopurine in individualized induction therapy of adult acute myeloid leukemia:the JALSG-AML92 study
- Genomic profiling of malignant pleural mesothelioma with array-based comparative genomic hybridization shows frequent non-random chromosomal alteration regions including JUN amplification on 1p32
- Phase III Study of Ranimustine, Cyclophosphamide, Vincristine, Melphalan, and Prednisolone (MCNU-COP/MP) versus Modified COP/MP in Multiple Myeloma : A Japan Clinical Oncology Group Study, JCOG 9301
- Gastric low-grade B-cell MALT lymphoma : treatment, response, and genetic alteration
- Clinicopathologic Comparison between the API2-MALT1 Chimeric Transcriptpositive and -negative Gastric low-grade B-Cell Lymphoma of Mucosa-associated Lymphoid Tissue Type
- Imatinib Provides Durable Molecular and Cytogenetic Responses in a Practical Setting for Both Newly Diagnosed and Previously Treated Chronic Myelogenous Leukemia : A Study in Nagasaki Prefecture, Japan
- Good Prognosis of Patients With Acute Promyelocytic Leukemia Who Achieved Second Complete Remission (CR) With a New Retinoid, Am80, After Relapse From CR Induced by All-trans-Retionic Acid
- Infectious complications during remission induction therapy in 577 patients with acute myeloid leukemia in the Japan Adult Leukemia Study Group studies between 1987 and 1991
- Impact of Established Risk Factors for Breast Cancer in Nulligravid Japanese Women
- Expression profiling analysis of the CD5^+ diffuse large B-cell lymphoma subgroup : Development of a CD5 signature
- Characterization of target genes at the 2p15-16 amplicon in diffuse large B-cell lymphoma
- Randomized phase II study of concurrent and sequential rituximab and CHOP chemotherapy in untreated indolent B-cell lymphoma
- Polymorphism of dihydropyrimidine dehydrogenase (DPYD) Cys29Arg and risk of six malignancies in Japanese
- Multicenter Prospective Study of Interferon-α and Conventional Chemotherapy Versus Bone Marrow Transplantation for Newly Diagnosed Patients With Chronic Myelogenous Leukemia
- Prognostic Significance of CD7^+CD56^+ Phenotype and Chromosome 5 Abnormalities for Acute Myeloid Leukemia M0
- Morphological spectrum of cyclin D1-positive mantle cell lymphoma : Study of 168 cases
- Effective and Safe Interferon Treatment for Japanese Patients With Chronic Myelogenous Leukemia Relapse After Bone Marrow Transplantation
- Comparison of genetic aberrations in CD10^+ diffused large B-cell lymphoma and follicular lymphoma by comparative genomic hybridization and tissue-fluorescence in situ hybridization
- MUM1/IRF4 Expression Is an Unfavorable Prognostic Factor in B-Cell Chronic Lymphocytic Leukemia(CLL)/Small Lymphocytic Lymphoma(SLL)
- CD34^+-Selected Autologous Peripheral Blood Stem Cell Transplantation Conditioned With Total Body Irradiation for Malignant Lymphoma: Increased Risk of Infectious Complications
- Assessment of Prognostic Factors in Follicular Lymphoma Patients
- Association of p53 Codon Arg72Pro and p73 G4C14-to-A4T14 at Exon 2 Genetic Polymorphisms with the Risk of Japanese Breast Cancer
- Folate Intake and Food Sources in Japanese Female Dietitians
- Reproducibility of a Semi-quantitative Food Frequency Questionnaire in Japanese Female Dietitians
- Impact of Family History on the Risk of Breast Cancer among the Japanese
- Heavy smoking history interacts with chemoradiotherapy for esophageal cancer prognosis : A retrospective study
- Phase II study of chemotherapy and stem cell transplantation for adult acute lymphoblastic leukemia or lymphoblastic lymphoma : Japan Clinical Oncology Group study 9004
- A Phase II Study of VEPA/FEPP Chemotherapy for Aggressive Lymphoma in Elderly Patients : Japan Clinical Oncology Group Study JCOG9203
- A Randomized Controlled Trial Investigating the Survival Benefit of Dose-Intensified Multidrug Combination Chemotherapy (LSG9) for Intermediate- or High-Grade Non-Hodgkin's Lymphoma : Japan Clinical Oncology Group Study 9002
- Deoxycoformycin-Containing Combination Chemotherapy for Adult T-Cell Leukemia-Lymphoma : Japan Clinical Oncology Group Study (JCOG9109)
- Clinical Aspects of Multimodality Therapy for Resectable Locoregional Esophageal Cancer
- NAD(P)H : quinone oxidoreductase 1 (NQ01) C609T polymorphism and the risk of eight cancers for Japanese
- Physical exercise reduces risk of breast cancer in Japanese women
- Transforming Growth Factor B1 T29C Polymorphism and Breast Cancer Risk in Japanese Women
- Ratio of Expression of p16^ to p14^ Correlates with the Progression of Non-small Cell Lung Cancer
- Elevated Serum Vascular Endothelial Growth Factor and Basic Fibroblast Growth Factor Levels in Patients with Thymic Epithelial Neoplasms
- Expression of Periostin, Homologous with an Insect Cell Adhesion Molecule,as a Prognostic Marker in Non-small Cell Lung Cancers
- Combination of Subareolar Blue Dye and Peritumoral RI for Sentinel Lymph Node Biopsy
- Localization of Gelatinolytic Activity Can Be Detected in Breast Cancer Tissues by Film in situ Zymography
- Limited association between a catechol-O-methyltransferase (CONT) polymorphism and breast cancer risk in Japan
- No Association of the 5' Promoter Region Polymorphism of CYP17 with Breast Cancer Risk in Japan
- A Case of Metastatic Breast Cancer Achieving Complete Response by Combination Therapy with 5'-Deoxy-5-fluorouridine and Cyclophosphamide
- Identification of Cancer Antigens in Breast Cancer by the SEREX Expression Cloning Method
- High-resolution melting analysis for a reliable and two-step scanning of mutations in the tyrosine kinase domain of the chimerical bcr-abl gene.
- A Phase II Study of S-1 in Patients with Metastatic Breast Cancer : A Japanese Trial by the S-1 Cooperative Study Group, Breast Cancer Working Group
- Hematopoietic stem cell transplantation for therapy-related myelodysplastic syndrome and acute leukemia : a single-center analysis of 47 patients
- Early Detection of Plasma Cytomegalovirus DNA by Real-Time PCR after Allogeneic Hematopoietic Stem Cell Transplantation
- Irrespective of CD34 expression, lineage-committed cell fraction reconstitutes and re-establishes transformed Philadelphia chromosome-positive leukemia in NOD/SCID/IL-2Rγc^ mice
- Novel processing techniques of pH and heat stable chitosan nano-particles
- Superior Mesenteric Venous Thrombosis Associated With a Familial Missense Mutation (Pro626Leu) in the SHBG-Like Domain of the Protein S Molecule
- Acute myeloid leukemia in the elderly : 159 Nagoya case studies
- L-myc Genotype is Associated with Different Susceptibility to Lung Cancer in Smokers
- Different Susceptibility of Each L-myc Genotype to Esophageal Cancer Risk Factors
- Synergistic action of the microRNA-17 polycistron and Myc in aggressive cancer development
- Latex protein induced delayed-type contact allergy
- A case of contact dermatitis due to water-soluble licorice extract
- A case of contact dermatitis due to glycol salicylate
- Patients' Views on Residual Blood Use for Research Purposes
- Randomized trial of cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil with node-positive breast cancer in Japan
- Phase I/II and pharmacokinetic study of cladribine with 2-h infusion in Japanese patients with relapsed indolent B-cell lymphoma mostly pretreated with rituximab
- Some components of adipic polyesters induce allergic contact dermatitis
- Study about the stinging sensation due to a tacrolimus ointment on atopic dermatitis patients
- Five cases of latex allergy from 1998 to 2000
- Three cases of lip dermatitis due to diisostearyl malate
- Phase II study of 4-weekly capecitabine monotherapy in advanced/metastatic breast cancer
- Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia : the JALSG-ALL97 study
- Phase II study of ABVd therapy for newly diagnosed clinical stage II-IV Hodgkin lymphoma : Japan Clinical Oncology Group study (JCOG 9305)
- Comparison between self-reported facial flushing after alcohol consumption and ALDH2 Glu504Lys polymorphism for risk of upper aerodigestive tract cancer in a Japanese population
- LKB1 Gene Alterations in Surgically Resectable Adenocarcinoma of the Lung
- Phase I trial of gemtuzumab ozogamicin in intensive combination chemotherapy for relapsed or refractory adult acute myeloid leukemia (AML) : Japan Adult Leukemia Study Group (JALSG)-AML206 study
- Analysis of bacteremia/fungemia and pneumonia accompanying acute myelogenous leukemia from 1987 to 2001 in the Japan Adult Leukemia Study Group
- Lack of non-hematological cross intolerance of dasatinib to imatinib in imatinib-intolerant patients with Philadelphia chromosome positive chronic myeloid leukemia or acute lymphatic leukemia : a retrospective safety analysis
- Prognostic Factors of Pathologic Stage IB Non-small Cell Lung Cancer
- Profile of Participants and Genotype Distributions of 108 Polymorphisms in a Cross-Sectional Study of Associations of Genotypes With Lifestyle and Clinical Factors : A Project in the Japan Multi-Institutional Collaborative Cohort (J-MICC) Study
- Successful treatment of a chronic-phase T-315I-mutated chronic myelogenous leukemia patient with a combination of imatinib and interferon-alfa
- Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011
- A novel clinical entity, IgG4-related disease (IgG4RD) : general concept and details
- Rituximab monotherapy with eight weekly infusions for relapsed or refractory patients with indolent B cell non-Hodgkin lymphoma mostly pretreated with rituximab : A multicenter phase II study
- An Instructive Case Suggesting Warfarin Resistance Which is Independent on the Regulation of the CYP2C9 and VKORC1 Genotype
- Heterogeneity in clonal nature in the smoldering subtype of adult T-cell leukemia : continuity from carrier status to smoldering ATL
- Phase II study of cyclophosphamide, doxorubicin, vincristine, prednisolone (CHOP) therapy for newly diagnosed patients with low-and low-intermediate risk, aggressive non-Hodgkin's lymphoma : final results of the Japan Clinical Oncology Group Study, JCOG95
- Randomized comparison of fixed-schedule versus response-oriented individualized induction therapy and use of ubenimex during and after consolidation therapy for elderly patients with acute myeloid leukemia : the JALSG GML200 Study